Royal Bank of Canada
BIOS

Royal Bank of Canada’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Royal Bank of Canada’s Portfolio BIOS Stock Details BIOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-145
Closed -$2K – 7871
2023
Q1 		$2K Sell
145
-800
-85% -$8.29K ﹤0.01% 6831
2022
Q4 		$10K Sell
945
-1,079
-53% -$10.9K ﹤0.01% 6561
2022
Q3 		$20K Sell
2,024
-176
-8% -$1.76K ﹤0.01% 6155
2022
Q2 		$22K Hold
2,200
– – ﹤0.01% 6079
2022
Q1 		$22K Buy
+2,200
New +$21.7K ﹤0.01% 6564

Other funds holding BIOS

WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Royal Bank of Canada's BIOS Position: Q2 2023 in Review

Royal Bank of Canada sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q2 2023, closing a stake of 145 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in BIOS in Q1 2022 and held it in 5 quarters. The position peaked at $22K in Q2 2022. 32 funds tracked by Wall St. Rank hold BIOS as of Q2 2023.

  • Royal Bank of Canada reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 145 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q2 2023, an estimated $2K.
  • Royal Bank of Canada first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 5 quarters.
  • Royal Bank of Canada's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $22K in Q2 2022.
  • 32 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q2 2023.

Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.